Oral contraceptives

Psychosomatics

Volumn 49, Issue 2, 2008, Pages 168-175

  Oesterheld, Jessica R ^a   Cozza, Kelly ^b,c   Sandson, Neil B ^d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; APREPITANT; ATORVASTATIN; BOSENTAN; CARBAMAZEPINE; CYTOCHROME P450; DAPSONE; DESOGESTREL PLUS ETHINYLESTRADIOL; EFAVIRENZ; ERYTHROMYCIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; FELBAMATE; FLUCONAZOLE; FLUOXETINE; GENORA; GRISEOFULVIN; HYPERICUM PERFORATUM EXTRACT; ISOTRETINOIN; LEVONORGESTREL; MESTRANOL PLUS NORETHISTERONE; MESTRANOL PLUS NORETYNODREL; MODAFINIL; NELFINAVIR; NEVIRAPINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; RIFABUTIN; RIFAMPICIN; RITONAVIR; TOPIRAMATE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIRTH CONTROL; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG SULFATION; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; ORAL CONTRACEPTION; REVIEW;

EID: 40549122276     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.2.168     Document Type: Article

References (107)

1. J. Schmider D.J. Greenblatt L.L. von Miltke Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P450 2C9 and metabolic inhibitors J Clin Pharmacol 37 1997 193 200
2. F.P. Guengerich Metabolism of 17-alpha-ethynylestradiol in humans Life Sci 47 1990 1981 1988
3. H. Zhang D. Cui B. Wang Pharmacokinetic drug interactions involving 17-alpha-ethinylestradiol: a new look at an old drug Clin Pharmacokinet 46 2007 133 157
4. R. Raftogianis C. Creveling R. Weinshilboum Estrogen metabolism by conjugation J Natl Cancer Inst Monogr 27 2000 113 124
5. W.C. Song Biochemistry and reproductive endocrinology of estrogen sulfotransferase Ann N Y Acad Sci 948 2001 43 50
6. A.A. Adjei R.M. Weinshilboum Catecholestrogen sulfation: possible role in carcinogenesis Biochem Biophys Res Commun 292 2002 402 408
7. T. Korhonen A. Tolonen J. Uusitalo The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel Br J Clin Pharmacol 60 2005 69 75
8. C.P. van Dijke J.C. Weber Interaction between oral contraceptives and griseofulvin BMJ (Clin Res Ed) 288 1984 1125 1126
9. J.V. Joshi U.M. Joshi G.M. Sankolli A study of interaction of a low-dose combination oral contraceptive with anti-tubercular drugs Contraception 21 1980 617 629
10. P. Barditch-Crovo C.B. Trapnell E. Ette The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive Clin Pharmacol Ther 65 1999 428 438
11. C.M. Loi R. Stern J.R. Koup Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent J Clin Pharmacol 39 1999 410 417
12. A.M. Baciewicz Oral contraceptive drug interactions Ther Drug Monit 7 1985 26 35
13. C. Fattore G. Cipolla G. Gatti Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women Epilepsia 40 1999 783 787
14. C.L. Harden I. Leppik Optimizing therapy of seizures in women who use oral contraceptives Neurology 67 12,suppl 4 2006 S56 S58
15. S. Matalon S. Schechtman G. Goldzweig The teratogenic effect of carbamazepine: a meta-analysis of 1,255 exposures Reprod Toxicol 16 2002 9 17
16. M. Bialer D.R. Doose B. Murthy Pharmacokinetic interactions of topiramate Clin Pharmacokinet 43 2004 763 780
17. W.E. Rosenfeld D.R. Doose S.A. Walker Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy Epilepsia 38 1997 317 323
18. V. Saano P. Glue C.R. Banfield Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive Clin Pharmacol Ther 58 1995 523 531
19. D. Ouellet A. Hsu J. Qian Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers Br J Clin Pharmacol 46 1998 111 116
20. D. Mildvan R. Yarish A. Marshak Pharmacokinetic interaction between nevirapine and ethinylestradiol/norethindrone when administered concurrently to HIV-infected women J Acquir Immune Defic Syndr 29 2002 471 477
21. L.B. Moore B. Goodwin S.A. Jones St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc Natl Acad Sci U S A 97 2000 7500 7502
22. P.A. Murphy S.E. Kern F.Z. Stanczyk Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity, and breakthrough bleeding Contraception 71 2005 402 408
23. L.V. Sarino K.H. Dang N. Dianat Drug interactions between oral contraceptives and St. John's Wort: appropriateness of advice received from community pharmacists and health-food store clerks J Am Pharm Assoc (Washington, DC). 47 2007 42 47
24. P. Robertson Jr. E.T. Hellriegel S. Arora Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers Clin Pharmacol Ther 71 2002 46 56
25. P. Crawford D. Chadwick P. Cleland The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids Contraception 33 1986 23 29
26. M.A. Eldon B.A. Underwood E.J. Randinitis Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol Neurology 50 1998 1146 1148
27. Holdich T, Whiteman P, Orme M, et al. Effect of lamotrigine on the pharmacology of the combined oral contraceptive pill (abstract). Epilepsia 1991; 32(suppl 1):96.
28. Z. Hussein J. Posner Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data Br J Clin Pharmacol 43 1997 457 465
29. G. Sills M. Brodie Pharmacokinetics and drug interactions with zonisamide Epilepsia 48 2007 435 441
30. A. Bartoli G. Gatti G. Cipolla A double-blind, placebo-controlled study on the effect of vigabatrin on in-vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers Epilepsia 38 1997 702 707
31. K. Venkatakrishnan D.J. Greenblatt L.L. von Moltke Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4 J Clin Pharmacol 38 1998 112 121
32. S.M. Tsunoda R.Z. Harris P.J. Mroczkowski Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women J Clin Pharmacol 38 1998 1137 1143
33. P.L. van Giersbergen A. Halabi J. Dingemanse Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol Int J Clin Pharmacol Ther 44 2006 113 118
34. C.W. Hendrix K.A. Jackson E. Whitmore The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone Clin Pharmacol Ther 75 2004 464 475
35. C.B. Trapnell M. Connolly H. Pentikis Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females Ann Pharmacother 41 2007 222 228
36. L. Shane-McWhorter J.D. Cerveny L.L. MacFarlane Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy Pharmacotherapy 18 1998 1360 1364
37. M. Haukkamaa Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment Contraception 33 1986 559 565
38. V. Odlind S.E. Olsson Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants Contraception 33 1986 257 261
39. P. Crawford D.J. Chadwick C. Martin The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids Br J Clin Pharmacol 30 1990 892 896
40. S.B. Teal D.M. Ginosar Contraception for women with chronic medical conditions Obstet Gynecol Clin North Am 34 2007 113 126
41. A. Guberman Hormonal contraception and epilepsy Neurology 53 suppl 1 1999 838 840
42. (No authors):Use of rifampin and contraceptive steroids. Br J Fam Plan 1999; 24:169–170
43. J. Hilbert M. Messig O. Kuye Evaluation of interaction between fluconazole and an oral contraceptive in healthy women Obstet Gynecol 98 2001 218 223
44. F.E. Sinofsky S.A. Pasquale The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives Am J Obstet Gynecol 178 1998 300 304
45. B. Meyer F. Muller P. Wessels A model to detect interactions between roxithromycin and oral contraceptives Clin Pharmacol Ther 47 1990 671 674
46. D. Pessayre Effects of macrolide antibiotics on drug metabolism in rats and in humans Int J Clin Pharmacol Res 3 1983 449 458
47. D.P. Wermeling M.H. Chandler G.D. Sides Dirithromycin increases ethinyl estradiol clearance without allowing ovulation Obstet Gynecol 86 1995 78 84
48. J.V. Joshi A. Maitra G. Sankolli Norethisterone and ethinyl estradiol kinetics during dapsone therapy J Assoc Physicians India 32 1984 191 193
49. A. Weber R. Jager A. Borner Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 53 1996 41 47
50. F.P. Guengerich Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs Am J Obstet Gynecol 163 1990 2159 2163
51. R. Lawrenson R. Farmer Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference? Contraception 62 suppl 2 2000 S21 S28
52. D.E. Adson M. Kotlyar A probable interaction between a very-low-dose oral contraceptive and the antidepressant nefazodone: a case report J Clin Psychopharmacol 21 2001 618 619
53. T.S. Tracy C. Marra S.A. Wrighton Studies of flurbiprofen 4′-hydroxylation: additional evidence suggesting the sole involvement of cytochrome P450 2C9 Biochem Pharmacol 52 1996 1305 1309
54. X. Wen J.S. Wang J.T. Backman Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively Drug Metab Dispos 30 2002 631 635
55. A. Gunes E. Bilir H. Zengil Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients Basic Clin Pharmacol Toxicol 100 2007 383 386
56. M. Niemi J.T. Backman M. Neuvonen Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride Clin Pharmacol Ther 69 2001 194 200
57. D.R. Abernethy E.L. Todd Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives Eur J Clin Pharmacol 28 1985 425 428
58. L. Gu F.J. Gonzalez W. Kalow Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by cDNAexpressed human CYP1A2 and CYP2E1 Pharmacogenetics 2 1992 73 77
59. R.K. Roberts J. Grice C. McGuffie Oral contraceptive steroids impair the elimination of theophylline J Lab Clin Med 101 1983 821 825
60. K.M. Tornatore R. Kanarkowski T.L. McCarthy Effect of chronic oral contraceptive steroids on theophylline disposition Eur J Clin Pharmacol 23 1982 129 134
61. Z.-Y. Zhang L.S. Kaminsky Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation Biochem Pharmacol 50 1995 205 211
62. J.H. Jonkman Therapeutic consequences of drug interactions with theophylline pharmacokinetics J Allergy Clin Immunol 78 1986 736 742
63. K. Yoshimoto H. Echizen K. Chiba Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-desisopropylation is mediated mainly by CYP1A2 Br J Clin Pharmacol 39 1995 421 431
64. T. Walle T.C. Fagan U.K. Walle Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women Br J Clin Pharmacol 41 1996 305 309
65. T. Walle U.K. Walle T.D. Cowart Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects Clin Pharmacol Ther 46 1989 257 263
66. V. Gabbay M.A. O’Dowd M. Mamamtavrishvili Clozapine and oral contraceptives: a possible drug interaction J Clin Psychopharmacol 22 2002 621 622
67. M. Chetty R. Miller Oral contraceptives increase the plasma concentrations of chlorpromazine Ther Drug Monit 23 2001 556 558
68. K. Laine S. Palovaara P. Tapanainen Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy Clin Pharmacol Ther 66 1999 602 608
69. M.T. Granfors J.T. Backman J. Laitila Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2 Clin Pharmacol Ther 78 2005 400 411
70. S. Palovaara O. Pelkonen J. Uusitalo Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation Clin Pharmacol Ther 74 2003 326 333
71. S. Hagg O. Spigset R. Dahlqvist Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers Br J Clin Pharmacol 51 2001 169 173
72. K. Laine G. Tybring L. Bertilsson No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects Clin Pharmacol Ther 68 2000 151 159
73. W.J. Tamminga J. Wemer B. Oosterhuis CYP2D6 and CYP2C19 activity in a large population of Dutch healthy vol unteers: indications for oral contraceptive-related gender differences Eur J Clin Pharmacol 55 1999 177 184
74. E.A. De Leacy C.D. McLeay M.J. Eadie Effects of subjects’ sex, and intake of tobacco, alcohol, and oral contraceptives on plasma phenytoin levels Br J Clin Pharmacol 8 1979 33 36
75. K. Laine M. Anttila A. Helminen Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids Br J Clin Pharmacol 47 1999 249 254
76. J.G. Bramness S. Skurtveit M. Gulliksen The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects Eur J Clin Pharmacol 61 2005 499 506
77. S. Palovaara G. Tybring K. Laine The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects Br J Clin Pharmacol 56 2003 232 237
78. R. McGready K. Stepniewska E. Seaton Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil Eur J Clin Pharmacol 59 2003 553 557
79. D.I. Belle J.T. Callaghan J.C. Gorski The effects of an oral contraceptive containing ethinylestradiol and norgestrel on CYP3A activity Br J Clin Pharmacol 53 2002 67 74
80. S. Palovaara K.T. Kivisto P. Tapanainen Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1-hydroxylation Br J Clin Pharmacol 50 2000 333 337
81. G. Deray P. le Hoang P. Cacoub Oral contraceptive interaction with cyclosporin Lancet 1 1987 158 159
82. J. Seidegard M. Simonsson Edsbacker S: Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol Clin Pharmacol Ther 67 2000 373 381
83. K. Fotherby Intrasubject variability in the pharmacokinetics of ethynyloestradiol J Steroid Biochem Mol Biol 38 1991 733 736
84. D.R. Abernethy D.J. Greenblatt M. Divoll Impairment of diazepam metabolism by low-dose, estrogen-containing oral contraceptive steroids N Engl J Med 306 1982 791 792
85. D.R. Abernethy D.J. Greenblatt R.I. Shader Imipramine disposition in users of oral contraceptive steroids Clin Pharmacol Ther 35 1984 792 797
86. P.M. Edelbroek F.G. Zitman E.A. Knoppert-van der Klein Therapeutic drug monitoring of amitriptyline: impact of age, smoking, and contraceptives on drug and metabolite levels in bulimic women Clin Chim Acta 165 1987 177 187
87. F. Jung T.H. Richardson J.L. Raucy Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases Drug Metab Dispos 25 1997 133 139
88. E. Koyama K. Chiba M. Tani Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and 11 recombinant human CYPs J Pharmacol Exp Ther 281 1997 1199 1210
89. R.V. Patwardhan M.C. Mitchell R.F. Johnson Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines Hepatology 3 1983 248 253
90. S. Ono T. Hatanaka S. Miyazawa Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19, and the 3A subfamily Xenobiotica 26 1996 1155 1166
91. K. Laine U. Yasar J. Widen A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19, and 3A4 activities in human liver microsomes Pharmacol Toxicol 93 2003 77 81
92. N.L. Benowitz C.N. Lessov-Schlaggar G.E. Swan Female sex and oral contraceptive use accelerate nicotine metabolism Clin Pharmacol Ther 79 2006 480
93. J.O. Miners R.A. Robson D.J. Birkett Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination Br J Clin Pharmacol 18 1984 240 243
94. H.F. Liu J. Magdalou A. Nicolas Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats Gen Pharmacol 22 1991 393 397
95. H. Monig C. Baese H.T. Heidemann Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon Br J Clin Pharmacol 30 1990 115 118
96. R.J. Herman G.R. Loewen D.M. Antosh Analysis of polymorphic variation in drug metabolism. III: glucuronidation and sulfation of diflunisal in man Clin Invest Med 17 1994 297 307
97. A. Sabers J.M. Buckholt P. Uldall Lamotrigine plasma levels reduced by oral contraceptives Epilepsy Res 47 2001 151 154
98. M. Contin F. Albani G. Ambrosetto Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy Epilepsia 47 2006 1573 1575
99. J. Christensen V. Petrenaite J. Atterman Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial Epilepsia 48 2007 484 489
100. C.A. Galimberti I. Mazzucchelli C. Arbasino Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy Epilepsia 47 2006 1569 1572
101. D.R. Abernethy D.J. Greenblatt H.R. Ochs Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives Clin Pharmacol Ther 33 1983 628 632
102. G.P. Stoehr P.D. Kroboth R.P. Juhl Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics Clin Pharmacol Ther 36 1984 683 690
103. M.H. Court S.X. Duan L.L. von Moltke Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms J Pharmacol Exp Ther 299 2001 998 1006
104. M.C. Mitchell T. Hanew C.G. Meredith Effects of oral contraceptive steroids on acetaminophen metabolism and elimination Clin Pharmacol 34 1983 48 53
105. S.M. Rogers D.J. Back P.J. Stevenson Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol Br J Clin Pharmacol 23 1987 721 725
106. T.P. Dooley Molecular biology of the human phenol sulfotransferase gene family J Exp Zool 282 1998 223 230
107. G. Hocking W.F. deMello Taking a “drugs” history Anaesthesia 52 1997 904 905